nodes	percent_of_prediction	percent_of_DWPC	metapath
Molindone—Dyspnoea—Fulvestrant—breast cancer	0.00319	0.00488	CcSEcCtD
Molindone—Vision blurred—Letrozole—breast cancer	0.00319	0.00488	CcSEcCtD
Molindone—Dyspnoea—Toremifene—breast cancer	0.00315	0.00482	CcSEcCtD
Molindone—Muscle spasms—Raloxifene—breast cancer	0.00309	0.00472	CcSEcCtD
Molindone—Euphoric mood—Fluorouracil—breast cancer	0.00308	0.0047	CcSEcCtD
Molindone—Constipation—Fulvestrant—breast cancer	0.00306	0.00468	CcSEcCtD
Molindone—Leukopenia—Anastrozole—breast cancer	0.00303	0.00463	CcSEcCtD
Molindone—Leukopenia—Letrozole—breast cancer	0.00303	0.00463	CcSEcCtD
Molindone—Weight increased—Tamoxifen—breast cancer	0.00302	0.00463	CcSEcCtD
Molindone—Constipation—Toremifene—breast cancer	0.00302	0.00462	CcSEcCtD
Molindone—Weight decreased—Tamoxifen—breast cancer	0.00301	0.0046	CcSEcCtD
Molindone—Urinary retention—Thiotepa—breast cancer	0.00299	0.00457	CcSEcCtD
Molindone—Amenorrhoea—Docetaxel—breast cancer	0.00294	0.0045	CcSEcCtD
Molindone—Weight increased—Goserelin—breast cancer	0.00289	0.00442	CcSEcCtD
Molindone—Leukopenia—Idarubicin—breast cancer	0.00287	0.0044	CcSEcCtD
Molindone—Dysphagia—Vinorelbine—breast cancer	0.00284	0.00435	CcSEcCtD
Molindone—Drowsiness—Goserelin—breast cancer	0.00283	0.00433	CcSEcCtD
Molindone—Dry mouth—Anastrozole—breast cancer	0.00282	0.00431	CcSEcCtD
Molindone—Dry mouth—Letrozole—breast cancer	0.00282	0.00431	CcSEcCtD
Molindone—Dyspnoea—Exemestane—breast cancer	0.00277	0.00424	CcSEcCtD
Molindone—Hypotension—Ixabepilone—breast cancer	0.00274	0.00419	CcSEcCtD
Molindone—Tachycardia—Letrozole—breast cancer	0.0027	0.00412	CcSEcCtD
Molindone—Constipation—Exemestane—breast cancer	0.00266	0.00407	CcSEcCtD
Molindone—Dyspnoea—Ixabepilone—breast cancer	0.00261	0.004	CcSEcCtD
Molindone—Weight decreased—Vinorelbine—breast cancer	0.00257	0.00393	CcSEcCtD
Molindone—Constipation—Ixabepilone—breast cancer	0.00251	0.00384	CcSEcCtD
Molindone—Weight increased—Thiotepa—breast cancer	0.00247	0.00378	CcSEcCtD
Molindone—Dyspnoea—Anastrozole—breast cancer	0.00246	0.00377	CcSEcCtD
Molindone—Dyspnoea—Letrozole—breast cancer	0.00246	0.00377	CcSEcCtD
Molindone—Somnolence—Letrozole—breast cancer	0.00246	0.00376	CcSEcCtD
Molindone—Somnolence—Anastrozole—breast cancer	0.00246	0.00376	CcSEcCtD
Molindone—Rash—Lapatinib—breast cancer	0.00245	0.00375	CcSEcCtD
Molindone—Dermatitis—Lapatinib—breast cancer	0.00245	0.00375	CcSEcCtD
Molindone—Tremor—Chlorambucil—breast cancer	0.00244	0.00373	CcSEcCtD
Molindone—Agitation—Chlorambucil—breast cancer	0.00239	0.00366	CcSEcCtD
Molindone—Constipation—Letrozole—breast cancer	0.00236	0.00361	CcSEcCtD
Molindone—Constipation—Anastrozole—breast cancer	0.00236	0.00361	CcSEcCtD
Molindone—Leukopenia—Chlorambucil—breast cancer	0.00233	0.00356	CcSEcCtD
Molindone—Nausea—Lapatinib—breast cancer	0.00231	0.00354	CcSEcCtD
Molindone—Rash—Fulvestrant—breast cancer	0.00226	0.00345	CcSEcCtD
Molindone—Dermatitis—Fulvestrant—breast cancer	0.00225	0.00345	CcSEcCtD
Molindone—Dysphagia—Fluorouracil—breast cancer	0.00225	0.00344	CcSEcCtD
Molindone—Rash—Toremifene—breast cancer	0.00223	0.00341	CcSEcCtD
Molindone—Muscle spasms—Tamoxifen—breast cancer	0.00223	0.00341	CcSEcCtD
Molindone—Dermatitis—Toremifene—breast cancer	0.00222	0.0034	CcSEcCtD
Molindone—Weight increased—Mitoxantrone—breast cancer	0.00213	0.00326	CcSEcCtD
Molindone—Leukopenia—Vinblastine—breast cancer	0.00213	0.00326	CcSEcCtD
Molindone—Muscle spasms—Goserelin—breast cancer	0.00213	0.00325	CcSEcCtD
Molindone—Nausea—Fulvestrant—breast cancer	0.00213	0.00325	CcSEcCtD
Molindone—Weight decreased—Mitoxantrone—breast cancer	0.00212	0.00324	CcSEcCtD
Molindone—Weight decreased—Irinotecan—breast cancer	0.00212	0.00324	CcSEcCtD
Molindone—Nausea—Toremifene—breast cancer	0.0021	0.00321	CcSEcCtD
Molindone—Drowsiness—Mitoxantrone—breast cancer	0.00209	0.0032	CcSEcCtD
Molindone—Vision blurred—Goserelin—breast cancer	0.00208	0.00319	CcSEcCtD
Molindone—Leukopenia—Tamoxifen—breast cancer	0.00207	0.00317	CcSEcCtD
Molindone—Leukopenia—Melphalan—breast cancer	0.00203	0.0031	CcSEcCtD
Molindone—Amenorrhoea—Epirubicin—breast cancer	0.00198	0.00303	CcSEcCtD
Molindone—Leukopenia—Goserelin—breast cancer	0.00198	0.00303	CcSEcCtD
Molindone—Rash—Exemestane—breast cancer	0.00196	0.003	CcSEcCtD
Molindone—Dermatitis—Exemestane—breast cancer	0.00196	0.003	CcSEcCtD
Molindone—Dry mouth—Tamoxifen—breast cancer	0.00193	0.00295	CcSEcCtD
Molindone—Dysphagia—Paclitaxel—breast cancer	0.00191	0.00293	CcSEcCtD
Molindone—Dyskinesia—Epirubicin—breast cancer	0.00185	0.00284	CcSEcCtD
Molindone—Rash—Ixabepilone—breast cancer	0.00185	0.00283	CcSEcCtD
Molindone—Dermatitis—Ixabepilone—breast cancer	0.00185	0.00283	CcSEcCtD
Molindone—Nausea—Exemestane—breast cancer	0.00185	0.00282	CcSEcCtD
Molindone—Dry mouth—Goserelin—breast cancer	0.00184	0.00282	CcSEcCtD
Molindone—Amenorrhoea—Doxorubicin—breast cancer	0.00184	0.00281	CcSEcCtD
Molindone—Tachycardia—Melphalan—breast cancer	0.00181	0.00276	CcSEcCtD
Molindone—Disturbance in sexual arousal—Capecitabine—breast cancer	0.0018	0.00276	CcSEcCtD
Molindone—Vision blurred—Thiotepa—breast cancer	0.00178	0.00273	CcSEcCtD
Molindone—Leukopenia—Vinorelbine—breast cancer	0.00177	0.00271	CcSEcCtD
Molindone—Tachycardia—Goserelin—breast cancer	0.00176	0.00269	CcSEcCtD
Molindone—Nausea—Ixabepilone—breast cancer	0.00174	0.00266	CcSEcCtD
Molindone—Rash—Letrozole—breast cancer	0.00174	0.00266	CcSEcCtD
Molindone—Rash—Anastrozole—breast cancer	0.00174	0.00266	CcSEcCtD
Molindone—Weight increased—Paclitaxel—breast cancer	0.00174	0.00266	CcSEcCtD
Molindone—Dermatitis—Letrozole—breast cancer	0.00174	0.00266	CcSEcCtD
Molindone—Dermatitis—Anastrozole—breast cancer	0.00174	0.00266	CcSEcCtD
Molindone—Agitation—Thiotepa—breast cancer	0.00174	0.00266	CcSEcCtD
Molindone—Weight decreased—Paclitaxel—breast cancer	0.00173	0.00265	CcSEcCtD
Molindone—Hypotension—Melphalan—breast cancer	0.00173	0.00265	CcSEcCtD
Molindone—Urinary retention—Capecitabine—breast cancer	0.00173	0.00264	CcSEcCtD
Molindone—Dyskinesia—Doxorubicin—breast cancer	0.00172	0.00262	CcSEcCtD
Molindone—Leukopenia—Thiotepa—breast cancer	0.00169	0.00259	CcSEcCtD
Molindone—Salivary hypersecretion—Epirubicin—breast cancer	0.00169	0.00259	CcSEcCtD
Molindone—Hypotension—Goserelin—breast cancer	0.00169	0.00258	CcSEcCtD
Molindone—Dyspnoea—Tamoxifen—breast cancer	0.00169	0.00258	CcSEcCtD
Molindone—Gynaecomastia—Methotrexate—breast cancer	0.00167	0.00255	CcSEcCtD
Molindone—Constipation—Vinblastine—breast cancer	0.00166	0.00254	CcSEcCtD
Molindone—Rash—Raloxifene—breast cancer	0.00165	0.00253	CcSEcCtD
Molindone—Rash—Idarubicin—breast cancer	0.00165	0.00253	CcSEcCtD
Molindone—Dermatitis—Raloxifene—breast cancer	0.00165	0.00253	CcSEcCtD
Molindone—Dermatitis—Idarubicin—breast cancer	0.00165	0.00253	CcSEcCtD
Molindone—Dyspnoea—Melphalan—breast cancer	0.00165	0.00252	CcSEcCtD
Molindone—Nausea—Letrozole—breast cancer	0.00164	0.00251	CcSEcCtD
Molindone—Nausea—Anastrozole—breast cancer	0.00164	0.00251	CcSEcCtD
Molindone—Dysphagia—Docetaxel—breast cancer	0.00162	0.00248	CcSEcCtD
Molindone—Constipation—Tamoxifen—breast cancer	0.00162	0.00247	CcSEcCtD
Molindone—Dyspnoea—Goserelin—breast cancer	0.00161	0.00246	CcSEcCtD
Molindone—Somnolence—Goserelin—breast cancer	0.0016	0.00245	CcSEcCtD
Molindone—Tachycardia—Vinorelbine—breast cancer	0.00158	0.00241	CcSEcCtD
Molindone—Muscle spasms—Irinotecan—breast cancer	0.00157	0.0024	CcSEcCtD
Molindone—Dysphagia—Capecitabine—breast cancer	0.00157	0.0024	CcSEcCtD
Molindone—Salivary hypersecretion—Doxorubicin—breast cancer	0.00157	0.0024	CcSEcCtD
Molindone—Nausea—Idarubicin—breast cancer	0.00156	0.00238	CcSEcCtD
Molindone—Nausea—Raloxifene—breast cancer	0.00156	0.00238	CcSEcCtD
Molindone—Constipation—Goserelin—breast cancer	0.00154	0.00236	CcSEcCtD
Molindone—Vision blurred—Mitoxantrone—breast cancer	0.00154	0.00236	CcSEcCtD
Molindone—Hypotension—Vinorelbine—breast cancer	0.00151	0.00231	CcSEcCtD
Molindone—Tachycardia—Thiotepa—breast cancer	0.00151	0.00231	CcSEcCtD
Molindone—Weight increased—Docetaxel—breast cancer	0.00148	0.00226	CcSEcCtD
Molindone—Vision blurred—Fluorouracil—breast cancer	0.00147	0.00226	CcSEcCtD
Molindone—Weight decreased—Docetaxel—breast cancer	0.00147	0.00224	CcSEcCtD
Molindone—Leukopenia—Mitoxantrone—breast cancer	0.00146	0.00224	CcSEcCtD
Molindone—Leukopenia—Irinotecan—breast cancer	0.00146	0.00224	CcSEcCtD
Molindone—Dyspnoea—Vinorelbine—breast cancer	0.00144	0.0022	CcSEcCtD
Molindone—Weight increased—Capecitabine—breast cancer	0.00143	0.00218	CcSEcCtD
Molindone—Leukopenia—Gemcitabine—breast cancer	0.00142	0.00218	CcSEcCtD
Molindone—Weight decreased—Capecitabine—breast cancer	0.00142	0.00217	CcSEcCtD
Molindone—Leukopenia—Fluorouracil—breast cancer	0.0014	0.00214	CcSEcCtD
Molindone—Constipation—Vinorelbine—breast cancer	0.00138	0.00211	CcSEcCtD
Molindone—Somnolence—Thiotepa—breast cancer	0.00137	0.0021	CcSEcCtD
Molindone—Constipation—Thiotepa—breast cancer	0.00132	0.00202	CcSEcCtD
Molindone—Tachycardia—Mitoxantrone—breast cancer	0.0013	0.00199	CcSEcCtD
Molindone—Muscle spasms—Paclitaxel—breast cancer	0.00128	0.00196	CcSEcCtD
Molindone—Nausea—Chlorambucil—breast cancer	0.00126	0.00193	CcSEcCtD
Molindone—Vision blurred—Paclitaxel—breast cancer	0.00126	0.00192	CcSEcCtD
Molindone—Tremor—Paclitaxel—breast cancer	0.00125	0.00191	CcSEcCtD
Molindone—Tachycardia—Fluorouracil—breast cancer	0.00125	0.00191	CcSEcCtD
Molindone—Hypotension—Mitoxantrone—breast cancer	0.00125	0.00191	CcSEcCtD
Molindone—Hypotension—Irinotecan—breast cancer	0.00125	0.00191	CcSEcCtD
Molindone—Agitation—Paclitaxel—breast cancer	0.00122	0.00187	CcSEcCtD
Molindone—Hypotension—Gemcitabine—breast cancer	0.00121	0.00186	CcSEcCtD
Molindone—Hypotension—Fluorouracil—breast cancer	0.00119	0.00183	CcSEcCtD
Molindone—Leukopenia—Paclitaxel—breast cancer	0.00119	0.00182	CcSEcCtD
Molindone—Rash—Tamoxifen—breast cancer	0.00119	0.00182	CcSEcCtD
Molindone—Dermatitis—Tamoxifen—breast cancer	0.00119	0.00182	CcSEcCtD
Molindone—Dyspnoea—Mitoxantrone—breast cancer	0.00119	0.00182	CcSEcCtD
Molindone—Dyspnoea—Irinotecan—breast cancer	0.00119	0.00182	CcSEcCtD
Molindone—Somnolence—Irinotecan—breast cancer	0.00119	0.00181	CcSEcCtD
Molindone—Somnolence—Mitoxantrone—breast cancer	0.00119	0.00181	CcSEcCtD
Molindone—Rash—Melphalan—breast cancer	0.00117	0.00178	CcSEcCtD
Molindone—Dermatitis—Melphalan—breast cancer	0.00117	0.00178	CcSEcCtD
Molindone—Dyspnoea—Gemcitabine—breast cancer	0.00116	0.00177	CcSEcCtD
Molindone—Nausea—Vinblastine—breast cancer	0.00116	0.00177	CcSEcCtD
Molindone—Somnolence—Gemcitabine—breast cancer	0.00115	0.00177	CcSEcCtD
Molindone—Constipation—Irinotecan—breast cancer	0.00114	0.00174	CcSEcCtD
Molindone—Constipation—Mitoxantrone—breast cancer	0.00114	0.00174	CcSEcCtD
Molindone—Dyspnoea—Fluorouracil—breast cancer	0.00114	0.00174	CcSEcCtD
Molindone—Rash—Goserelin—breast cancer	0.00114	0.00174	CcSEcCtD
Molindone—Dermatitis—Goserelin—breast cancer	0.00114	0.00174	CcSEcCtD
Molindone—Somnolence—Fluorouracil—breast cancer	0.00114	0.00174	CcSEcCtD
Molindone—Nausea—Tamoxifen—breast cancer	0.00112	0.00172	CcSEcCtD
Molindone—Constipation—Gemcitabine—breast cancer	0.00111	0.0017	CcSEcCtD
Molindone—Dry mouth—Paclitaxel—breast cancer	0.00111	0.0017	CcSEcCtD
Molindone—Nausea—Melphalan—breast cancer	0.0011	0.00168	CcSEcCtD
Molindone—Dysphagia—Epirubicin—breast cancer	0.00109	0.00167	CcSEcCtD
Molindone—Muscle spasms—Docetaxel—breast cancer	0.00109	0.00166	CcSEcCtD
Molindone—Nausea—Goserelin—breast cancer	0.00107	0.00164	CcSEcCtD
Molindone—Tachycardia—Paclitaxel—breast cancer	0.00106	0.00162	CcSEcCtD
Molindone—Muscle spasms—Capecitabine—breast cancer	0.00105	0.00161	CcSEcCtD
Molindone—Drowsiness—Methotrexate—breast cancer	0.00104	0.00159	CcSEcCtD
Molindone—Vision blurred—Capecitabine—breast cancer	0.00103	0.00158	CcSEcCtD
Molindone—Tremor—Capecitabine—breast cancer	0.00102	0.00157	CcSEcCtD
Molindone—Rash—Vinorelbine—breast cancer	0.00102	0.00156	CcSEcCtD
Molindone—Dermatitis—Vinorelbine—breast cancer	0.00102	0.00156	CcSEcCtD
Molindone—Hypotension—Paclitaxel—breast cancer	0.00102	0.00155	CcSEcCtD
Molindone—Dysphagia—Doxorubicin—breast cancer	0.00101	0.00155	CcSEcCtD
Molindone—Leukopenia—Docetaxel—breast cancer	0.00101	0.00155	CcSEcCtD
Molindone—Weight increased—Epirubicin—breast cancer	0.000995	0.00152	CcSEcCtD
Molindone—Weight decreased—Epirubicin—breast cancer	0.000989	0.00151	CcSEcCtD
Molindone—Leukopenia—Capecitabine—breast cancer	0.000979	0.0015	CcSEcCtD
Molindone—Drowsiness—Epirubicin—breast cancer	0.000975	0.00149	CcSEcCtD
Molindone—Rash—Thiotepa—breast cancer	0.000974	0.00149	CcSEcCtD
Molindone—Dermatitis—Thiotepa—breast cancer	0.000973	0.00149	CcSEcCtD
Molindone—Dyspnoea—Paclitaxel—breast cancer	0.00097	0.00148	CcSEcCtD
Molindone—Somnolence—Paclitaxel—breast cancer	0.000967	0.00148	CcSEcCtD
Molindone—Nausea—Vinorelbine—breast cancer	0.00096	0.00147	CcSEcCtD
Molindone—Dry mouth—Docetaxel—breast cancer	0.00094	0.00144	CcSEcCtD
Molindone—Constipation—Paclitaxel—breast cancer	0.00093	0.00142	CcSEcCtD
Molindone—Weight increased—Doxorubicin—breast cancer	0.000921	0.00141	CcSEcCtD
Molindone—Nausea—Thiotepa—breast cancer	0.000917	0.0014	CcSEcCtD
Molindone—Weight decreased—Doxorubicin—breast cancer	0.000915	0.0014	CcSEcCtD
Molindone—Dry mouth—Capecitabine—breast cancer	0.00091	0.00139	CcSEcCtD
Molindone—Drowsiness—Doxorubicin—breast cancer	0.000902	0.00138	CcSEcCtD
Molindone—Tachycardia—Docetaxel—breast cancer	0.0009	0.00138	CcSEcCtD
Molindone—Tachycardia—Capecitabine—breast cancer	0.000871	0.00133	CcSEcCtD
Molindone—Hypotension—Docetaxel—breast cancer	0.000861	0.00132	CcSEcCtD
Molindone—Rash—Mitoxantrone—breast cancer	0.000841	0.00129	CcSEcCtD
Molindone—Rash—Irinotecan—breast cancer	0.000841	0.00129	CcSEcCtD
Molindone—Dermatitis—Irinotecan—breast cancer	0.00084	0.00128	CcSEcCtD
Molindone—Dermatitis—Mitoxantrone—breast cancer	0.00084	0.00128	CcSEcCtD
Molindone—Hypotension—Capecitabine—breast cancer	0.000834	0.00128	CcSEcCtD
Molindone—Dyspnoea—Docetaxel—breast cancer	0.000822	0.00126	CcSEcCtD
Molindone—Somnolence—Docetaxel—breast cancer	0.000819	0.00125	CcSEcCtD
Molindone—Rash—Gemcitabine—breast cancer	0.000819	0.00125	CcSEcCtD
Molindone—Dermatitis—Gemcitabine—breast cancer	0.000818	0.00125	CcSEcCtD
Molindone—Rash—Fluorouracil—breast cancer	0.000805	0.00123	CcSEcCtD
Molindone—Dermatitis—Fluorouracil—breast cancer	0.000804	0.00123	CcSEcCtD
Molindone—Dyspnoea—Capecitabine—breast cancer	0.000796	0.00122	CcSEcCtD
Molindone—Nausea—Irinotecan—breast cancer	0.000792	0.00121	CcSEcCtD
Molindone—Nausea—Mitoxantrone—breast cancer	0.000792	0.00121	CcSEcCtD
Molindone—Constipation—Docetaxel—breast cancer	0.000788	0.00121	CcSEcCtD
Molindone—Nausea—Gemcitabine—breast cancer	0.000772	0.00118	CcSEcCtD
Molindone—Vision blurred—Methotrexate—breast cancer	0.000767	0.00117	CcSEcCtD
Molindone—Constipation—Capecitabine—breast cancer	0.000763	0.00117	CcSEcCtD
Molindone—Nausea—Fluorouracil—breast cancer	0.000759	0.00116	CcSEcCtD
Molindone—Muscle spasms—Epirubicin—breast cancer	0.000732	0.00112	CcSEcCtD
Molindone—Leukopenia—Methotrexate—breast cancer	0.000729	0.00111	CcSEcCtD
Molindone—Vision blurred—Epirubicin—breast cancer	0.000718	0.0011	CcSEcCtD
Molindone—Agitation—Epirubicin—breast cancer	0.0007	0.00107	CcSEcCtD
Molindone—Rash—Paclitaxel—breast cancer	0.000686	0.00105	CcSEcCtD
Molindone—Dermatitis—Paclitaxel—breast cancer	0.000685	0.00105	CcSEcCtD
Molindone—Leukopenia—Epirubicin—breast cancer	0.000682	0.00104	CcSEcCtD
Molindone—Muscle spasms—Doxorubicin—breast cancer	0.000678	0.00104	CcSEcCtD
Molindone—Vision blurred—Doxorubicin—breast cancer	0.000664	0.00102	CcSEcCtD
Molindone—Agitation—Doxorubicin—breast cancer	0.000648	0.000991	CcSEcCtD
Molindone—Nausea—Paclitaxel—breast cancer	0.000646	0.000988	CcSEcCtD
Molindone—Dry mouth—Epirubicin—breast cancer	0.000634	0.00097	CcSEcCtD
Molindone—Leukopenia—Doxorubicin—breast cancer	0.000631	0.000965	CcSEcCtD
Molindone—Hypotension—Methotrexate—breast cancer	0.000621	0.00095	CcSEcCtD
Molindone—Tachycardia—Epirubicin—breast cancer	0.000607	0.000928	CcSEcCtD
Molindone—Dyspnoea—Methotrexate—breast cancer	0.000592	0.000906	CcSEcCtD
Molindone—Somnolence—Methotrexate—breast cancer	0.000591	0.000903	CcSEcCtD
Molindone—Dry mouth—Doxorubicin—breast cancer	0.000587	0.000898	CcSEcCtD
Molindone—Rash—Docetaxel—breast cancer	0.000581	0.000889	CcSEcCtD
Molindone—Hypotension—Epirubicin—breast cancer	0.000581	0.000889	CcSEcCtD
Molindone—Dermatitis—Docetaxel—breast cancer	0.000581	0.000888	CcSEcCtD
Molindone—Rash—Capecitabine—breast cancer	0.000563	0.000861	CcSEcCtD
Molindone—Dermatitis—Capecitabine—breast cancer	0.000562	0.00086	CcSEcCtD
Molindone—Tachycardia—Doxorubicin—breast cancer	0.000561	0.000859	CcSEcCtD
Molindone—Dyspnoea—Epirubicin—breast cancer	0.000554	0.000848	CcSEcCtD
Molindone—Somnolence—Epirubicin—breast cancer	0.000553	0.000845	CcSEcCtD
Molindone—Nausea—Docetaxel—breast cancer	0.000548	0.000837	CcSEcCtD
Molindone—Hypotension—Doxorubicin—breast cancer	0.000538	0.000822	CcSEcCtD
Molindone—Constipation—Epirubicin—breast cancer	0.000532	0.000813	CcSEcCtD
Molindone—Nausea—Capecitabine—breast cancer	0.00053	0.000811	CcSEcCtD
Molindone—Dyspnoea—Doxorubicin—breast cancer	0.000513	0.000785	CcSEcCtD
Molindone—Somnolence—Doxorubicin—breast cancer	0.000511	0.000782	CcSEcCtD
Molindone—Constipation—Doxorubicin—breast cancer	0.000492	0.000752	CcSEcCtD
Molindone—Rash—Methotrexate—breast cancer	0.000419	0.000641	CcSEcCtD
Molindone—Dermatitis—Methotrexate—breast cancer	0.000419	0.00064	CcSEcCtD
Molindone—Nausea—Methotrexate—breast cancer	0.000395	0.000604	CcSEcCtD
Molindone—Rash—Epirubicin—breast cancer	0.000392	0.0006	CcSEcCtD
Molindone—Dermatitis—Epirubicin—breast cancer	0.000392	0.000599	CcSEcCtD
Molindone—Nausea—Epirubicin—breast cancer	0.000369	0.000565	CcSEcCtD
Molindone—Rash—Doxorubicin—breast cancer	0.000363	0.000555	CcSEcCtD
Molindone—Dermatitis—Doxorubicin—breast cancer	0.000362	0.000554	CcSEcCtD
Molindone—Nausea—Doxorubicin—breast cancer	0.000342	0.000523	CcSEcCtD
Molindone—CHRM1—Signaling Pathways—PIK3CG—breast cancer	3.09e-05	8.91e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—APC—breast cancer	3.09e-05	8.91e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—EGF—breast cancer	3.07e-05	8.86e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—KDR—breast cancer	3.06e-05	8.85e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—EGF—breast cancer	3.05e-05	8.81e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—MAPK3—breast cancer	3.02e-05	8.72e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—ESR1—breast cancer	2.99e-05	8.63e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—NOS3—breast cancer	2.98e-05	8.61e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—SRC—breast cancer	2.98e-05	8.6e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—MAPK3—breast cancer	2.97e-05	8.58e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PIK3CD—breast cancer	2.97e-05	8.57e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—BRAF—breast cancer	2.96e-05	8.56e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—MAPK3—breast cancer	2.96e-05	8.54e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—FN1—breast cancer	2.95e-05	8.52e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—ALB—breast cancer	2.93e-05	8.46e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—BRAF—breast cancer	2.92e-05	8.42e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—NFKBIA—breast cancer	2.91e-05	8.42e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—BRAF—breast cancer	2.9e-05	8.38e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—VEGFA—breast cancer	2.9e-05	8.37e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IGF1—breast cancer	2.89e-05	8.34e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—NOTCH1—breast cancer	2.89e-05	8.34e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—AKT2—breast cancer	2.89e-05	8.33e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—EGFR—breast cancer	2.87e-05	8.3e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—STAT3—breast cancer	2.87e-05	8.29e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IGF1—breast cancer	2.84e-05	8.21e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—PIK3CA—breast cancer	2.84e-05	8.2e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—AKT2—breast cancer	2.84e-05	8.2e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MDM2—breast cancer	2.83e-05	8.17e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—EGFR—breast cancer	2.83e-05	8.16e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IGF1—breast cancer	2.83e-05	8.16e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—AKT2—breast cancer	2.82e-05	8.16e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—KIT—breast cancer	2.82e-05	8.15e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PIK3CG—breast cancer	2.82e-05	8.15e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—APC—breast cancer	2.82e-05	8.15e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—RAF1—breast cancer	2.82e-05	8.14e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—EGFR—breast cancer	2.81e-05	8.12e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—RELA—breast cancer	2.81e-05	8.11e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—NOS3—breast cancer	2.8e-05	8.09e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—EGF—breast cancer	2.79e-05	8.06e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—ERBB2—breast cancer	2.79e-05	8.05e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PIK3CD—breast cancer	2.77e-05	8.01e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PIK3CB—breast cancer	2.75e-05	7.95e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MTOR—breast cancer	2.75e-05	7.95e-05	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—PIK3CA—breast cancer	2.75e-05	7.93e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—MAPK3—breast cancer	2.74e-05	7.92e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—SERPINE1—breast cancer	2.74e-05	7.92e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PIK3CD—breast cancer	2.73e-05	7.88e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—KRAS—breast cancer	2.71e-05	7.84e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PIK3CD—breast cancer	2.71e-05	7.84e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—MAPK3—breast cancer	2.7e-05	7.81e-05	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—PIK3CA—breast cancer	2.7e-05	7.8e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—SERPINE1—breast cancer	2.7e-05	7.79e-05	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—PIK3CA—breast cancer	2.69e-05	7.76e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—SERPINE1—breast cancer	2.68e-05	7.75e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—KRAS—breast cancer	2.67e-05	7.71e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—MYC—breast cancer	2.67e-05	7.7e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—TGFB1—breast cancer	2.66e-05	7.68e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—KRAS—breast cancer	2.66e-05	7.67e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—BRAF—breast cancer	2.65e-05	7.66e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CXCL8—breast cancer	2.64e-05	7.64e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—HRAS—breast cancer	2.63e-05	7.59e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—NOS3—breast cancer	2.62e-05	7.56e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—EGFR—breast cancer	2.61e-05	7.53e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PIK3CB—breast cancer	2.59e-05	7.47e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IGF1—breast cancer	2.58e-05	7.47e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—AKT2—breast cancer	2.58e-05	7.46e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CDKN1B—breast cancer	2.58e-05	7.46e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—NOS3—breast cancer	2.58e-05	7.44e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—EGFR—breast cancer	2.57e-05	7.43e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PTGS2—breast cancer	2.56e-05	7.4e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—NOS3—breast cancer	2.56e-05	7.4e-05	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—AKT1—breast cancer	2.55e-05	7.38e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CASP3—breast cancer	2.53e-05	7.31e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—IL2—breast cancer	2.53e-05	7.3e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—IL6—breast cancer	2.51e-05	7.26e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—PIK3CA—breast cancer	2.49e-05	7.2e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MDM2—breast cancer	2.48e-05	7.17e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PIK3CD—breast cancer	2.48e-05	7.17e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—RAF1—breast cancer	2.47e-05	7.15e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—KRAS—breast cancer	2.46e-05	7.12e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—RELA—breast cancer	2.46e-05	7.12e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CCND1—breast cancer	2.46e-05	7.12e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—JUN—breast cancer	2.46e-05	7.1e-05	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—PIK3CA—breast cancer	2.46e-05	7.1e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—SERPINE1—breast cancer	2.45e-05	7.09e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—PIK3CA—breast cancer	2.45e-05	7.09e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—ERBB2—breast cancer	2.45e-05	7.07e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MDM2—breast cancer	2.44e-05	7.06e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—PIK3CA—breast cancer	2.44e-05	7.05e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CTNNB1—breast cancer	2.44e-05	7.05e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—RAF1—breast cancer	2.44e-05	7.03e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MDM2—breast cancer	2.43e-05	7.02e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—KRAS—breast cancer	2.43e-05	7.02e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—RELA—breast cancer	2.42e-05	7e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—RAF1—breast cancer	2.42e-05	7e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MTOR—breast cancer	2.42e-05	6.98e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PIK3CB—breast cancer	2.42e-05	6.98e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—RELA—breast cancer	2.41e-05	6.96e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—ERBB2—breast cancer	2.41e-05	6.96e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—ERBB2—breast cancer	2.4e-05	6.92e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MMP9—breast cancer	2.39e-05	6.91e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CDKN1A—breast cancer	2.38e-05	6.88e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PTEN—breast cancer	2.38e-05	6.87e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PIK3CB—breast cancer	2.38e-05	6.87e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MTOR—breast cancer	2.38e-05	6.87e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MTOR—breast cancer	2.36e-05	6.83e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PIK3CB—breast cancer	2.36e-05	6.83e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—NOS3—breast cancer	2.34e-05	6.77e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MAPK8—breast cancer	2.33e-05	6.72e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CXCL8—breast cancer	2.32e-05	6.71e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—AKT1—breast cancer	2.32e-05	6.7e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—HRAS—breast cancer	2.31e-05	6.66e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CXCL8—breast cancer	2.28e-05	6.6e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CXCL8—breast cancer	2.27e-05	6.56e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—HRAS—breast cancer	2.27e-05	6.56e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CDKN1B—breast cancer	2.27e-05	6.55e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—PIK3CA—breast cancer	2.26e-05	6.54e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—HRAS—breast cancer	2.26e-05	6.52e-05	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—AKT1—breast cancer	2.24e-05	6.48e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PTEN—breast cancer	2.24e-05	6.46e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—PIK3CA—breast cancer	2.23e-05	6.45e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CDKN1B—breast cancer	2.23e-05	6.44e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MDM2—breast cancer	2.22e-05	6.42e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CASP3—breast cancer	2.22e-05	6.42e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CDKN1B—breast cancer	2.22e-05	6.41e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IL2—breast cancer	2.22e-05	6.41e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—RAF1—breast cancer	2.22e-05	6.4e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—IL6—breast cancer	2.21e-05	6.38e-05	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—AKT1—breast cancer	2.21e-05	6.37e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—RELA—breast cancer	2.21e-05	6.37e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—SRC—breast cancer	2.21e-05	6.37e-05	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—AKT1—breast cancer	2.2e-05	6.34e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—ERBB2—breast cancer	2.19e-05	6.33e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—TP53—breast cancer	2.19e-05	6.33e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CASP3—breast cancer	2.19e-05	6.32e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IL2—breast cancer	2.18e-05	6.31e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CASP3—breast cancer	2.18e-05	6.28e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—IL6—breast cancer	2.17e-05	6.27e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IL2—breast cancer	2.17e-05	6.27e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CCND1—breast cancer	2.16e-05	6.25e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MTOR—breast cancer	2.16e-05	6.25e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PIK3CB—breast cancer	2.16e-05	6.25e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—IL6—breast cancer	2.16e-05	6.24e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—JUN—breast cancer	2.16e-05	6.23e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—VEGFA—breast cancer	2.15e-05	6.2e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CTNNB1—breast cancer	2.14e-05	6.19e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CCND1—breast cancer	2.13e-05	6.15e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—STAT3—breast cancer	2.13e-05	6.14e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—JUN—breast cancer	2.12e-05	6.13e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CCND1—breast cancer	2.12e-05	6.11e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—JUN—breast cancer	2.11e-05	6.1e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CTNNB1—breast cancer	2.11e-05	6.09e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MMP9—breast cancer	2.1e-05	6.07e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CTNNB1—breast cancer	2.1e-05	6.06e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—HRAS—breast cancer	2.09e-05	6.05e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CDKN1A—breast cancer	2.09e-05	6.04e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PTEN—breast cancer	2.09e-05	6.03e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CXCL8—breast cancer	2.08e-05	6e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MMP9—breast cancer	2.07e-05	5.97e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—HRAS—breast cancer	2.07e-05	5.96e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CDKN1A—breast cancer	2.06e-05	5.95e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MMP9—breast cancer	2.06e-05	5.94e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PTEN—breast cancer	2.05e-05	5.93e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CDKN1A—breast cancer	2.05e-05	5.92e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PTEN—breast cancer	2.04e-05	5.9e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MAPK8—breast cancer	2.04e-05	5.9e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—AKT1—breast cancer	2.04e-05	5.88e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MAPK3—breast cancer	2.03e-05	5.87e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	2.03e-05	5.86e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MAPK8—breast cancer	2.01e-05	5.8e-05	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	2.01e-05	5.8e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—IL6—breast cancer	2e-05	5.79e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—AKT1—breast cancer	2e-05	5.79e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MAPK8—breast cancer	2e-05	5.77e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—AKT1—breast cancer	1.99e-05	5.76e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CASP3—breast cancer	1.99e-05	5.75e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IL2—breast cancer	1.99e-05	5.74e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—IL6—breast cancer	1.98e-05	5.71e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MYC—breast cancer	1.98e-05	5.71e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—TGFB1—breast cancer	1.97e-05	5.69e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CCND1—breast cancer	1.94e-05	5.59e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—SRC—breast cancer	1.94e-05	5.59e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—EGFR—breast cancer	1.93e-05	5.58e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—JUN—breast cancer	1.93e-05	5.58e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	1.92e-05	5.54e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—SRC—breast cancer	1.91e-05	5.5e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—SRC—breast cancer	1.9e-05	5.47e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—VEGFA—breast cancer	1.89e-05	5.45e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MMP9—breast cancer	1.88e-05	5.43e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	1.87e-05	5.41e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PTEN—breast cancer	1.87e-05	5.4e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—STAT3—breast cancer	1.87e-05	5.39e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—VEGFA—breast cancer	1.86e-05	5.36e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—AKT1—breast cancer	1.85e-05	5.34e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—VEGFA—breast cancer	1.85e-05	5.33e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—STAT3—breast cancer	1.84e-05	5.31e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MAPK8—breast cancer	1.83e-05	5.28e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—STAT3—breast cancer	1.83e-05	5.28e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—KRAS—breast cancer	1.83e-05	5.27e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—AKT1—breast cancer	1.82e-05	5.27e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MAPK3—breast cancer	1.78e-05	5.15e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MAPK3—breast cancer	1.76e-05	5.07e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MAPK3—breast cancer	1.75e-05	5.04e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MYC—breast cancer	1.74e-05	5.01e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—SRC—breast cancer	1.73e-05	5.01e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—TGFB1—breast cancer	1.73e-05	5e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MYC—breast cancer	1.71e-05	4.93e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—TGFB1—breast cancer	1.7e-05	4.92e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MYC—breast cancer	1.7e-05	4.9e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—EGFR—breast cancer	1.7e-05	4.9e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—TGFB1—breast cancer	1.69e-05	4.89e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—VEGFA—breast cancer	1.69e-05	4.88e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PIK3CA—breast cancer	1.68e-05	4.85e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—STAT3—breast cancer	1.67e-05	4.83e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—EGFR—breast cancer	1.67e-05	4.82e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—EGFR—breast cancer	1.66e-05	4.8e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—TP53—breast cancer	1.62e-05	4.69e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—KRAS—breast cancer	1.6e-05	4.63e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MAPK3—breast cancer	1.6e-05	4.61e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—KRAS—breast cancer	1.58e-05	4.56e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PIK3CA—breast cancer	1.58e-05	4.55e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—KRAS—breast cancer	1.57e-05	4.53e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MYC—breast cancer	1.55e-05	4.49e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—HRAS—breast cancer	1.55e-05	4.48e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—TGFB1—breast cancer	1.55e-05	4.48e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—EGFR—breast cancer	1.52e-05	4.39e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—IL6—breast cancer	1.49e-05	4.29e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PIK3CA—breast cancer	1.47e-05	4.25e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PIK3CA—breast cancer	1.45e-05	4.19e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PIK3CA—breast cancer	1.44e-05	4.16e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—KRAS—breast cancer	1.44e-05	4.15e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—TP53—breast cancer	1.43e-05	4.12e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—TP53—breast cancer	1.4e-05	4.05e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—TP53—breast cancer	1.39e-05	4.03e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—AKT1—breast cancer	1.37e-05	3.96e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—HRAS—breast cancer	1.36e-05	3.94e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—HRAS—breast cancer	1.34e-05	3.87e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—HRAS—breast cancer	1.33e-05	3.85e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	1.32e-05	3.81e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IL6—breast cancer	1.3e-05	3.77e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—AKT1—breast cancer	1.29e-05	3.72e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IL6—breast cancer	1.28e-05	3.71e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IL6—breast cancer	1.28e-05	3.69e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—TP53—breast cancer	1.28e-05	3.68e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—HRAS—breast cancer	1.22e-05	3.52e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—AKT1—breast cancer	1.2e-05	3.48e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—AKT1—breast cancer	1.18e-05	3.42e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—AKT1—breast cancer	1.18e-05	3.4e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IL6—breast cancer	1.17e-05	3.37e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—AKT1—breast cancer	1.08e-05	3.11e-05	CbGpPWpGaD
